Companies

BIOMARIN PHARMACEUTICAL INC

BMRN · CIK 0001048477 · operating

$59.74-3.22%Last updated Mar 2, 11:00 PM

Key Statistics

Valuation

Market Cap$11.48B
P/E22.21
Fwd P/E8.95
PEG
P/S3.56
P/B1.89
EV/EBITDA14.62
EV/Rev3.28

Profitability

Gross Margin
Op. Margin12.71%
Net Margin10.83%
ROE5.73%
ROA4.59%
FCF Margin22.51%

Financial Health

Current Ratio5.21
Debt/Equity0.25
Free Cash Flow$724.96M
Div. Yield

Growth & Other

Revenue Growth12.87%
EPS Growth-18.55%
Beta0.26
52W High$73.51
52W Low$50.76

About BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC (BMRN) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $11.5 billion, BIOMARIN PHARMACEUTICAL INC is a large-cap company. The stock currently trades at $59.74, down 3.22% today, with a 52-week range of $50.76–$73.51. The company trades at a trailing P/E of 22.2x and a forward P/E of 8.9x.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$1.80$1.82-18.6%
2024$2.21$2.25+154.0%
2023$0.87$0.89+16.0%
2022$0.75$0.76+314.3%
2021$-0.35$-0.35-107.7%
2020$4.53$4.75+3584.6%
2019$-0.13$-0.13+70.5%
2018$-0.44$-0.44+34.3%
2017$-0.67$-0.67+82.4%
2016$-3.81$-3.80
2015
2014
2013
2012$-0.95$-0.95-97.9%
2011$-0.48$-0.48-127.7%
2010$1.73$2.00

Annual Reports (10-K) · 10 filings

Report DateFiledAccession Number
2025-12-312026-02-260001048477-26-000004SEC ↗
2024-12-312025-02-240001048477-25-000007SEC ↗
2023-12-312024-02-260001048477-24-000016SEC ↗
2022-12-312023-02-270001048477-23-000009SEC ↗
2021-12-312022-02-250001048477-22-000012SEC ↗
2020-12-312021-02-260001048477-21-000008SEC ↗
2019-12-312020-02-270001048477-20-000009SEC ↗
2018-12-312019-02-280001564590-19-005033SEC ↗
2017-12-312018-02-260001564590-18-003114SEC ↗
2016-12-312017-02-270001564590-17-002483SEC ↗